In the BioHarmony Drug Report Database
Metaproterenol
Alupent (metaproterenol) is a small molecule pharmaceutical. Metaproterenol was first approved as Alupent on 1982-01-01. It is used to treat asthma, bronchial spasm, chronic bronchitis, and pulmonary emphysema in the USA. The pharmaceutical is active against beta-2 adrenergic receptor.
Trade Name
|
Alupent |
|---|---|
Common Name
|
metaproterenol |
ChEMBL ID
|
CHEMBL776 |
Indication
|
asthma, bronchial spasm, chronic bronchitis, pulmonary emphysema |
Drug Class
|
Image (chem structure or protein)